Clinical Trial Categories
Anal Trials
Trial ID 20189 STAR
NCT04472429clinicaltrials.gov ID
USOR ID: 20189
Phase III
A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy
